Development of nonspecific interstitial pneumonitis associated with long-term treatment of primary pulmonary hypertension with prostacyclin

被引：15

作者：

Kesten, S ^{[1
]}

Dainauskas, J ^{[1
]}

McLaughlin, V ^{[1
]}

Rich, S ^{[1
]}

机构：

[1] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA

来源：

CHEST | 1999年 / 116卷 / 02期

关键词：

interstitial lung disease; primary pulmonary hypertension; prostacyclin;

D O I：

10.1378/chest.116.2.566

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A young woman with primary pulmonary hypertension presented with interstitial lung disease approximately 5 years after successful treatment with IV prostacyclin, The pathology was consistent with nonspecific interstitial pneumonitis and was unresponsive to steroids and immunosuppressive medications. We speculate that further cases of this syndrome may be reported as more patients are living beyond 5 years with prostacyclin.

引用

页码：566 / 569

页数：4

共 50 条

[1] Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
Hoeper, MM
Schwarze, M
Ehlerding, S
Adler-Schuermeyer, A
Spiekerkoetter, E
Niedermeyer, J
Hamm, M
Fabel, H
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25): : 1866 - 1870
[2] LONG-TERM TREATMENT OF PRIMARY PULMONARY-HYPERTENSION WITH CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN)
HIGENBOTTAM, T
WELLS, F
WHEELDON, D
WALLWORK, J
LANCET, 1984, 1 (8385): : 1046 - 1047
[3] Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects
Rosenzweig, EB
Kerstein, D
Barst, RJ
CIRCULATION, 1999, 99 (14) : 1858 - 1865
[4] Long-term prostacyclin reduces pulmonary vascular resistance in severe primary pulmonary hypertension
Barst, RJ
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1998, 16 (03) : 253 - 254
[5] SURVIVAL IN PRIMARY PULMONARY-HYPERTENSION WITH LONG-TERM CONTINUOUS INTRAVENOUS PROSTACYCLIN
BARST, RJ
RUBIN, LJ
MCGOON, MD
CALDWELL, EJ
LONG, WA
LEVY, PS
ANNALS OF INTERNAL MEDICINE, 1994, 121 (06) : 409 - 415
[6] Long-term continuous intravenous infusion of prostacyclin for severe primary pulmonary hypertension
Okano, Y
Senju, S
Tsutsui, Y
Kyotani, S
Ishibashi, M
Yoshida, M
Kunieda, T
INTERNAL MEDICINE, 1997, 36 (11) : 794 - 798
[7] PRACTICAL EXPERIENCE OF LONG-TERM PROSTACYCLIN IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION
JONES, K
HIGENBOTTAM, T
WALLWORK, J
THORAX, 1985, 40 (03) : 232 - 233
[8] Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension
McLaughlin, VV
Genthner, DE
Panella, MM
Rich, S
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (05): : 273 - 277
[9] Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension
Wax, D
Garofano, R
Barst, RJ
CHEST, 1999, 116 (04) : 914 - 920
[10] Long-term effects of prostacyclin on hemodynamics in primary pulmonary hypertension: Are continued dose increases necessary?
McLaughlin, VV
Meyer, PM
Rich, S
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (02) : 287A - 287A

← 1 2 3 4 5 →